Real-time enrollment status for this absence epilepsy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06315322 |
| Recruiting Status | Recruiting |
| Condition | Absence Epilepsy |
| Phase | Clinical Trial |
| Target Enrollment | 120 participants |
| Active Locations | 5 sites in the US |
| Sponsor | UCB Biopharma SRL |
| Last Updated on CT.gov | January 16, 2026 (Jan 16, 2026) |
As of March 2, 2026: Clinical trial NCT06315322 is currently recruiting participants. This clinical trial study for absence epilepsy is actively seeking new participants at 5 locations across the United States. The study is sponsored by UCB Biopharma SRL. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06315322 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06315322 was last updated Jan 16, 2026 (January 16, 2026). HelloStudys verifies this status automatically.